Evidence map›Paper›PMID 41897642›Full record

ArticleDiagnostics (Basel, Switzerland)2026

A Complete Response to Immunotherapy in a Patient with Locally Advanced Squamous Cell Lung Cancer Harboring a Novel

Juan Carlos Redondo-González, Iñigo San Miguel, Marta Rodríguez-González, Juan Carlos Montero, José María Sayagués, Mar Abad Hernández, Emilio Fonseca Sánchez, Edel Del Barco-Morillo, Alejandro Olivares-Hernández

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan Carlos Redondo-GonzálezThoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca, 37007 Salamanca, Spain.ORCID 0009-0001-7368-2263
Iñigo San MiguelDepartment of Radiotherapy Oncology, University Hospital of Salamanca, 37007 Salamanca, Spain.
Marta Rodríguez-GonzálezDepartment of Pathology, University Hospital of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-8544-6201
Juan Carlos MonteroInstitute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.ORCID 0000-0003-4773-053X
José María SayaguésInstitute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.ORCID 0000-0003-0582-3500
Mar Abad HernándezDepartment of Pathology, University Hospital of Salamanca, 37007 Salamanca, Spain.
Emilio Fonseca SánchezThoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca, 37007 Salamanca, Spain.
Edel Del Barco-MorilloThoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca, 37007 Salamanca, Spain.
Alejandro Olivares-HernándezThoracic Oncology Unit, Department of Medical Oncology, University Hospital of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-1992-6105

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BRAF fusioncase reportnon-small cell lung cancertargeted therapies

Identifiers

PMID41897642
PMCPMC13025942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.